Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$106,301,845
+$72,501,907 QoQ
Shares Held
925,813
+78.6% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. ACLX ranks #28 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,301,845 | 925,813 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,799,938 | 518,404 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $35,539,609 | 432,882 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $34,078,228 | 517,513 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $30,329,041 | 462,333 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $47,403,387 | 618,117 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $63,229,760 | 757,152 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $30,082,796 | 545,077 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $48,459,793 | 696,762 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $37,367,316 | 673,285 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $3,776,654 | 105,258 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $8,825,487 | 279,111 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,339,739 | 108,398 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,825,871 | 123,495 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,815,148 | 96,705 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,394,742 | 77,143 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $14,552 | 1,038 | Shares | Defined | 2022-10-27 | |
| No filing history on record for this holder in this stock. | ||||||